Cell Source, Inc. (CLCS)

0.93 +0.13 (+16.25%) USD  |  OTCM  |  Apr 16, 16:00
More

Cell Source Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for CLCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Atossa Therapeutics, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
Kiora Pharmaceuticals, Inc. Upgrade